Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

O2 Concepts Oxlife Independence Model 301-0001

K-Number: K182454 · 2018-12-20

Decision Date2018-12-20
Product CodeCAW
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

O2 Concepts Oxlife Independence Model 301-0001 is a medical device manufactured by O2 Concepts, LLC. It received FDA 510(k) clearance on 2018-12-20 under approval number K182454. The device is classified under product code CAW. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the O2 Concepts Oxlife Independence Model 301-0001?

O2 Concepts Oxlife Independence Model 301-0001 is a medical device that received FDA 510(k) clearance on 2018-12-20. It is manufactured by O2 Concepts, LLC. The 510(k) number is K182454.

When was O2 Concepts Oxlife Independence Model 301-0001 approved by the FDA?

O2 Concepts Oxlife Independence Model 301-0001 received FDA 510(k) clearance on 2018-12-20, under approval number K182454.

What company makes O2 Concepts Oxlife Independence Model 301-0001?

O2 Concepts Oxlife Independence Model 301-0001 is manufactured by O2 Concepts, LLC.

What is the FDA product code for O2 Concepts Oxlife Independence Model 301-0001?

The FDA product code for O2 Concepts Oxlife Independence Model 301-0001 is CAW.

Related Clinical Trials

Related Devices (Code: CAW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.